Epilepsy Treatment Devices Market Size Worth $788.71 Million By 2032 | CAGR: 4.6%

The global epilepsy treatment devices market size is expected to reach USD 788.71 million by 2032, according to a new study by Polaris Market Research. The report “Epilepsy Treatment Devices Market Share, Size, Trends, Industry Analysis Report, By Product Type (Wearable Devices, Conventional Devices, Implantable Devices); By Technology; By End-User; By Region; Segment Forecast, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

An increased risk of endemic diseases like neurocysticercosis and malaria is to blame for the rising number of epilepsy cases. In addition, the variations in medical infrastructure, birth-related injuries, the increasing number of traffic accidents, and the availability of accessible care and health education programs are the primary drivers of the studied market. As the World Health Organization estimates, around 50 Mn people across the globe are who have epilepsy, making it one of the most common diseases. About 4 to 10 people in every 1,000 people are thought to be affected by this condition at any given time.

In the United States, the annual rate of status epilepticus in patients of all ages ranged from 18.3 to 41 per 100,000 people in November 2020. Because of the high prevalence of epilepsy, there has been an increase in the need for epilepsy monitoring equipment to ensure that patients receive the appropriate treatment.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/epilepsy-treatment-devices-market/request-for-sample

For instance, the USFDA granted Bio Serenity’s electroencephalography wearable device system 510(k) clearance in January 2021. IceCap EEG wearable device and Bio Serenity’s NeuronauteEEG system, both included in this clearance, are intended to enable physicians to easily monitor & evaluate the activity of epileptic patients’ brains.

Spanish startup mjn-NEURO introduced the mjn-SERAS in May 2022, which aids in seizure detection in the UK. It is a ground-breaking device that uses artificial intelligence to anticipate seizures up to three minutes in advance. Epitel, a manufacturer of a wearable electroencephalogram system, raised USD 12.5 Mn in funding for seizure detection in February 2022.

The BRAIN initiative, launched in the United States in April 2013 to encourage research and development (R&D) related to the functioning of the brain, is one of several government initiatives focused on developing novel and innovative devices. The Advanced Research Projects Activity (IARPA) joined the BRAIN initiative to develop non-invasive neural intervention devices to improve reasoning and problem-solving abilities.

Epilepsy Treatment Devices Market Report Highlights

• Conveni over the forecast period is due to the advantages of these devices, such as their portability, outstanding wireless readability, improved sensitivity rates in detecting seizures, improved mobility and quality of life for epileptic patients.
• Deep brain stimulation segment dominated the market in 2022 due to increase in the use of deep brain stimulators in the treatment of various neuromuscular conditions like dystonia, epilepsy, and Parkinson's disease.
• Hospital segment held the largest revenue share, due to the availability of trained medical staff in hospitals.
• In 2022, Europe dominated the global market, due to the large geriatric population and rising healthcare costs.
• The global players include Cerbomed, ElectroCore, Cyberonics, NeuroPace, Boston Scientific, Medtronic, Medpage, Cadwell Industries, General Electric, and Philips.

Polaris Market Research has segmented the epilepsy treatment devices market report based on product type, technology, end-user, and region:

Epilepsy Treatment Devices, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

• Wearable Devices
• Conventional Devices
• Implantable Devices

Epilepsy Treatment Devices, Technology Outlook (Revenue - USD Million, 2019 - 2032)

• Vagus Nerve Stimulator
• Responsive Neurostimulation
• Deep Brain Stimulation
• Accelerometry

Epilepsy Treatment Devices, End-User Outlook (Revenue - USD Million, 2019 - 2032)

• Hospitals
• Ambulatory Surgical Centers
• Neurology Centers

     Epilepsy Treatment Devices, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa